Science Explorer Back to mapMap

Most cited papers from Qserve Group (Netherlands)

What are the most cited papers from Qserve Group (Netherlands)?

The most cited paper from Qserve Group (Netherlands) is "Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery" (Marta M. Kijanka, Frank-Jan Warnders, Mohamed El Khattabi et al., 2013), with 147 citations. Next come "Recent trends in molecular diagnostics of yeast infections: from PCR to NGS" (134) and "Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform" (95).

Showing 50 of 56 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery Marta M. Kijanka, Frank-Jan Warnders, Mohamed El Khattabi et al. · European Journal of Nuclear Medicine and Molecular Imaging 18 Jun 2013 147
2 Recent trends in molecular diagnostics of yeast infections: from PCR to NGS Amir A. Arastehfar et al. · FEMS Microbiology Reviews Open access 31 May 2019 134
3 Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform Alex Klarenbeek, Khalil El Mazouari, Aline Desmyter et al. · mAbs Open access 27 May 2015 95
4 A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition D. Lutje Hulsik et al. · PLoS Pathogens Open access 7 Mar 2013 92
5 Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists Ali Işbilir, Jan Møller, Marta Arimont et al. · Proceedings of the National Academy of Sciences Open access 4 Nov 2020 81
6 Candidalysin delivery to the invasion pocket is critical for host epithelial damage induced by Candida albicans Selene Mogavero, Frank M. Sauer, Sascha Brunke et al. · Cellular Microbiology Open access 10 Jul 2021 73
7 Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs Timo W.M. De Groof, Vladimir Bobkov, Raimond Heukers et al. · Molecular and Cellular Endocrinology Open access 26 Jan 2019 66
8 Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer Aram S. A. van Brussel, Arthur L.L. Adams, Sabrina Oliveira et al. · Molecular Imaging and Biology Open access 20 Nov 2015 63
9 Nanobodies that Neutralize HIV Robin A. Weiss, C. Theo Verrips · Vaccines Open access 31 Jul 2019 60
10 CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry Anneleen Van Hout, Alex Klarenbeek, Vladimir Bobkov et al. · Biochemical Pharmacology Open access 17 Oct 2018 60
11 Towards an ultra-rapid smartphone- connected test for infectious diseases Valérian Turbé, Eleanor Ruth Gray, Victoria E. Lawson et al. · Scientific Reports Open access 14 Sep 2017 56
12 Unravelling the Molecular Basis of High Affinity Nanobodies against HIV p24: In Vitro Functional, Structural, and in Silico Insights Eleanor Ruth Gray, Jennifer C. Brookes, Christophe Caillat et al. · ACS Infectious Diseases Open access 7 Jun 2017 50
13 Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes Nika M. Strokappe, M. Benjamin Hock, Lucy Rutten et al. · Antibodies Open access 18 Jun 2019 48
14 Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1 Laura E. McCoy, Lucy Rutten, Dan Frampton et al. · PLoS Pathogens Open access 18 Dec 2014 47
15 Legomedicine─A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody–Nanoparticle Conjugates Sanne A. M. van Lith, Sander M. J. van Duijnhoven, Anna C. Navis et al. · Bioconjugate Chemistry Open access 3 Jan 2017 44
16 Endogenous DKK1 and FRZB Regulate Chondrogenesis and Hypertrophy in Three-Dimensional Cultures of Human Chondrocytes and Human Mesenchymal Stem Cells Leilei Zhong, Xiaobin Huang, Emilie Dooms Rodrigues et al. · Stem Cells and Development Open access 12 Oct 2016 42
17 Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies Timo W.M. De Groof, Nick D. Bergkamp, Raimond Heukers et al. · Nature Communications Open access 16 Jul 2021 39
18 Nanobody-mediated neutralization of candidalysin prevents epithelial damage and inflammatory responses that drive vulvovaginal candidiasis pathogenesis Marisa Valentine, Paul Rudolph, Axel Dietschmann et al. · mBio Open access 13 Feb 2024 38
19 VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells Raimond Heukers, Vida Mashayekhi, M. Ramirez-Escudero et al. · Antibodies Open access 4 Apr 2019 38
20 Neutralisation of HIV-1 cell-cell spread by human and llama antibodies Laura E. McCoy, Elisabetta Groppelli, Christophe Blanchetot et al. · Retrovirology Open access Oct 2014 38
21 Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design Alla Amcheslavsky, Aaron Wallace, Monir Ejemel et al. · Scientific Reports Open access 2 Feb 2021 37
22 Candidalysin Is the Hemolytic Factor of Candida albicans Selene Mogavero, Sarah Höfs, Alexa N. Lauer et al. · Toxins Open access 15 Dec 2022 34
23 Revealing the spatio-phenotypic patterning of cells in healthy and tumor tissues with mLSR-3D and STAPL-3D Ravian L. van Ineveld, Michiel Kleinnijenhuis, María Alieva et al. · Nature Biotechnology Open access 3 Jun 2021 34
24 Viral G Protein–Coupled Receptors: Attractive Targets for Herpesvirus-Associated Diseases Timo W.M. De Groof, Elizabeth Elder, Marco H. Siderius et al. · Pharmacological Reviews Open access 10 Mar 2021 34
25 A novel immuno-gold labeling protocol for nanobody-based detection of HER2 in breast cancer cells using immuno-electron microscopy Marta M. Kijanka, Elly G. van Donselaar, Wally H. Müller et al. · Journal of Structural Biology Open access 25 May 2017 34
26 Neutralization Properties of Simian Immunodeficiency Viruses Infecting Chimpanzees and Gorillas Hannah J. Barbian et al. · mBio Open access 22 Apr 2015 34
27 Expression of VHHs in Saccharomyces cerevisiae Andrea Gorlani, Hans de Haard, Theo C. Verrips · Methods in molecular biology Book chapter 2012 32
28 Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions Angela I. Schriek, Marlies M. van Haaren, Meliawati Poniman et al. · Frontiers in Immunology Open access 16 May 2022 31
29 Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies Mark Soave, Raimond Heukers, Barrie Kellam et al. · Cell chemical biology Open access 30 Jun 2020 29
30 Camelid heavy chain only antibody fragment domain against β‐site of amyloid precursor protein cleaving enzyme 1 inhibits β‐secretase activity in vitro and in vivo Bram Dorresteijn, Maarten Rotman, Dorien Faber et al. · FEBS Journal 6 Jul 2015 17
31 NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET Jelle van den Bor, Nick D. Bergkamp, Stephanie M. Anbuhl et al. · Cell Reports Methods Open access Mar 2023 16
32 Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity Rianne G. Bouma, Maarten K. Nijen Twilhaar, Hendrik J. Brink et al. · International Journal of Pharmaceutics Open access 23 May 2024 15
33 Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies Eva M. Struijf, Karla I. De la O Becerra, Maartje Ruyken et al. · Journal of Biological Chemistry Open access 24 Jun 2023 14
34 Molecular characterization of the CXCR4 / CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugates Gamal Anton Wakileh, Philipp Bierholz, Mara Kotthoff et al. · Experimental Hematology and Oncology Open access 23 Nov 2023 13
35 Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism Stephanie M. Anbuhl, Xavier Dervillez, Saskia Neubacher et al. · Biochemical Pharmacology Open access 2 Aug 2024 12
36 Stimulation of Collateral Vessel Growth by Inhibition of Galectin 2 in Mice Using a Single‐Domain Llama‐Derived Antibody Maurits R. Hollander, Matthijs F. Jansen, Luuk H G A Hopman et al. · Journal of the American Heart Association Open access 9 Oct 2019 12
37 Extremely thin layer plastification for focused‐ion beam scanning electron microscopy: an improved method to study cell surfaces and organelles of cultured cells Elly G. van Donselaar, Bram Dorresteijn, Dušan Popov‐Čeleketić et al. · Journal of Microscopy Open access 25 Mar 2018 10
38 Fluorescently tagged nanobodies and NanoBRET to study ligand-binding and agonist-induced conformational changes of full-length EGFR expressed in living cells Dehan Çömez, Jacqueline R. Glenn, Stephanie M. Anbuhl et al. · Frontiers in Immunology Open access 23 Nov 2022 9
39 Performance evaluation of InfectID-BSI: A rapid quantitative PCR assay for detecting sepsis-associated organisms directly from whole blood Lisa A. Simms, C. Davies, Nadeesha Jayasundara et al. · Journal of Microbiological Methods 12 Jul 2023 8
40 Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies Jord C. Stam, Steven de Maat, Dorien de Jong et al. · Scientific Reports Open access 4 Aug 2022 5
41 The development of single-domain VHH nanobodies that target the Candida albicans cell surface Giuseppe Buda De Cesare, Frank M. Sauer, Anna Kolecka et al. · Microbiology Spectrum Open access 7 Oct 2024 4
42 Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies Claudia V. Perez Almeria, Omolade Otun, Roman R. Schlimgen et al. · Nature Communications Open access 2 Dec 2025 3
43 Improvement of Proteolytic Stability Through In Silico Engineering Lucy Rutten, Hans de Haard, Theo C. Verrips · Methods in molecular biology Book chapter 2012 3
44 Indium-111-Labeled Single-Domain Antibody for In Vivo CXCR4 Imaging Using Single-Photon Emission Computed Tomography Muriel Aline Spahn, Stephanie Mareike Anbuhl, Kaat Luyten et al. · Bioconjugate Chemistry Open access 11 Mar 2025 2
45 Molecular Pharmacology of a Conformational‐Specific Extracellular Nanobody Against CXCR4 Mark Soave, Raimond Heukers, Martine J. Smit et al. · The FASEB Journal Apr 2019 2
46 Targeting the latent human cytomegalovirus reservoir with virus specific nanobodies Timo W.M. De Groof, Elizabeth Elder, Raimond Heukers et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 13 May 2020 2
47 Monitoring ligand-induced changes in receptor conformation with NanoBiT conjugated nanobodies Mark Soave, Raimond Heukers, Barrie Kellam et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 23 Apr 2020 2
48 Selection of VHHs Under Application Conditions Edward Dolk, Theo C. Verrips, Hans de Haard · Methods in molecular biology Book chapter 2012 2
49 DKK1 AND FRZB are necessary for chondrocyte (RE)differentiation and prevention of cell hypertrophy in 3D cultures of human chondrocytes and human mesenchymal stem cells Leilei Zhong, Xiaojian Huang, Elsa Rodrigues et al. · Osteoarthritis and Cartilage Open access 20 Mar 2016 2
50 Genetic Engineering of VHH Antibody Fragments for Efficient Site-Specific Conjugation to Polysaccharides Lin Zhong, Lisanne Morshuis, Michelle Koerselman et al. · Bioconjugate Chemistry Open access 23 May 2025 1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.